Format: PDF
The Global Cell Line Development Market is valued to grow at a CAGR of 11.51% during the forecast period 2019-2024. The rising biopharmaceutical industry is anticipated to drive the demand for cell line development procedures. In addition, supportive government initiatives and growing awareness pertaining to monoclonal antibodies application in cancer treatment are some of the factors expected to drive the regional industry growth.
1 Global Cell Line Development Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Cell Line Development Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Cell Line Development Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Cell Line Development Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Cell Line Development Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.1.1 Rising demand for monoclonal antibodies globally
6.2.1.2 Innovative technologies accelerating the scale-up of cell lines
6.2.1.3 Growth in vaccine production
6.2.2 Challenges
6.2.2.1 Development of stable and authentic cell lines
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Cell Line Development Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Cell Line Development Market – By Product (Market Size – & million/billion)
8.1 Reagents and media
8.2 Storage equipment
8.3 Incubators
8.4 Equipment
8.5 Bioreactors
8.6 Microscopes
8.7 Others
9 Global Cell Line Development Market – By Source
9.1 Insect
9.2 Mammalian
9.3 Amphibian
10 Global Cell Line Development Market – By Type
10.1 Primary Cell Lines
10.2 Continuous Cell Lines
10.3 Hybridomas
10.4 Recombinant Cell Lines
11 Global Cell Line Development Market – By Application
11.1 Toxicity Testing
11.2 Tissue Engineering
11.3 Bioproduction
11.4 Drug Discovery
11.5 Vaccines
11.6 Others
12 Global Cell Line Development Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Cell Line Development Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Cell Line Development Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Lonza Group AG
14.3 Sartorius AG
14.4 Selexis SA
14.5 Corning, Inc.
14.6 European Collection of Cell Cultures
14.7 American Type Culture Collection
14.8 GE Healthcare
14.9 Sigma-Aldrich Corporation
14.10 Thermo Fisher Scientific, Inc.
14.11 Wuxi Apptec
14.12 Company 11 & more
15 Global Cell Line Development Market – Appendix
15.1 Sources
15.2 Abbreviations
Take a look at this complimentary sample which comprises of a variety of market data points such as trend analyses, market estimates, and forecasts. You can explore and evaluate it on your own.
Send me Free SampleOr View Our License Options:
$3,850.00 – $5,850.00
Industry Coverage: Global Market Studies has a broad range of industry coverage, spanning various sectors such as healthcare, technology, retail, automotive, and many others. This means that clients can rely on us to provide valuable insights into their respective industries, helping them make informed business decisions.
Our team of experts has years of experience in the market research industry, and they have honed their skills in data analysis, market forecasting, and trend analysis. They are also adept at using advanced research tools and techniques to gather and analyze data, providing clients with accurate and reliable insights.
We understand that each client has unique research needs, and we tailor our research solutions to meet their specific requirements. We work closely with our clients to understand their objectives and provide customized research solutions that address their business challenges.
We are committed to innovation and are constantly exploring new research methods and techniques to provide our clients with cutting-edge insights. This enables us to stay ahead of the curve and deliver the best possible research outcomes.
At Global Market Studies, our clients are at the center of everything we do. We pride ourselves on providing excellent customer service and support, and we are always available to address our clients’ concerns and questions.
Accurate market data is crucial to a successful business strategy. With an 85% + accuracy in all reports, makes us one of the best and most accurate firms in the world.
Need Customized Report ?Call NowThe Global Cell Line Development Market is valued to grow at a CAGR of 11.51% during the forecast period 2019-2024. The rising biopharmaceutical industry is anticipated to drive the demand for cell line development procedures. In addition, supportive government initiatives and growing awareness pertaining to monoclonal antibodies application in cancer treatment are some of the factors expected to drive the regional industry growth.
1 Global Cell Line Development Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Cell Line Development Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Cell Line Development Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Cell Line Development Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Cell Line Development Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.1.1 Rising demand for monoclonal antibodies globally
6.2.1.2 Innovative technologies accelerating the scale-up of cell lines
6.2.1.3 Growth in vaccine production
6.2.2 Challenges
6.2.2.1 Development of stable and authentic cell lines
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Cell Line Development Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Cell Line Development Market – By Product (Market Size – & million/billion)
8.1 Reagents and media
8.2 Storage equipment
8.3 Incubators
8.4 Equipment
8.5 Bioreactors
8.6 Microscopes
8.7 Others
9 Global Cell Line Development Market – By Source
9.1 Insect
9.2 Mammalian
9.3 Amphibian
10 Global Cell Line Development Market – By Type
10.1 Primary Cell Lines
10.2 Continuous Cell Lines
10.3 Hybridomas
10.4 Recombinant Cell Lines
11 Global Cell Line Development Market – By Application
11.1 Toxicity Testing
11.2 Tissue Engineering
11.3 Bioproduction
11.4 Drug Discovery
11.5 Vaccines
11.6 Others
12 Global Cell Line Development Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Cell Line Development Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Cell Line Development Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Lonza Group AG
14.3 Sartorius AG
14.4 Selexis SA
14.5 Corning, Inc.
14.6 European Collection of Cell Cultures
14.7 American Type Culture Collection
14.8 GE Healthcare
14.9 Sigma-Aldrich Corporation
14.10 Thermo Fisher Scientific, Inc.
14.11 Wuxi Apptec
14.12 Company 11 & more
15 Global Cell Line Development Market – Appendix
15.1 Sources
15.2 Abbreviations
Unleashing revenue potential through strategic market research involves identifying untapped market opportunities, understanding consumer needs and preferences, and developing targeted strategies to capitalize on them. By leveraging data-driven insights, businesses can optimize product offerings, pricing strategies, and marketing efforts to drive revenue growth and stay ahead of competitors.
